CSC
IMUX icon

Caldwell Sutter Capital’s Immunic IMUX Stock Holding History

Caldwell Sutter Capital’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$154 Buy
+10
New +$123 ﹤0.01% 909
2026
Q1 		– Hold
0
– – – 885
2025
Q4 		– Hold
0
– – – 873
2025
Q3 		– Sell
-1
Closed -$9 – 865
2025
Q2 		$3 Hold
1
– – ﹤0.01% 850
2025
Q1 		$5 Hold
1
– – ﹤0.01% 882
2024
Q4 		$5 Hold
1
– – ﹤0.01% 893
2024
Q3 		$8 Hold
1
– – ﹤0.01% 900
2024
Q2 		$6 Hold
1
– – ﹤0.01% 915
2024
Q1 		$7 Hold
1
– – ﹤0.01% 911
2023
Q4 		$8 Hold
1
– – ﹤0.01% 948
2023
Q3 		$7 Hold
1
– – ﹤0.01% 882
2023
Q2 		$13 Buy
+1
New +$17 ﹤0.01% 857

Other funds holding IMUX

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Caldwell Sutter Capital's IMUX Position: Q2 2026 in Review

Caldwell Sutter Capital opened a new position in Immunic (IMUX) in Q2 2026: 10 shares worth $154. The stake represents ﹤0.01% of the portfolio and ranks #909 among its holdings. This is a return to the name: Caldwell Sutter Capital previously reported a position in IMUX as recently as Q2 2025.

Caldwell Sutter Capital first reported a position in IMUX in Q2 2023 and has held it in 10 quarters since. 55 funds tracked by Wall St. Rank hold IMUX as of Q2 2026.

  • Caldwell Sutter Capital held 10 shares of Immunic worth $154 as of Q2 2026.
  • Immunic was a new Caldwell Sutter Capital position in Q2 2026.
  • Immunic made up ﹤0.01% of Caldwell Sutter Capital's portfolio in Q2 2026, its #909 holding.
  • Caldwell Sutter Capital first reported a position in Immunic in Q2 2023 and has held it in 10 quarters since.
  • 55 funds tracked by Wall St. Rank held Immunic as of Q2 2026.

Based on Caldwell Sutter Capital's 13F filing for Q2 2026, filed 5 Aug 2026.